Aerie Pharmaceuticals, Inc. Shareholders' Equity
Aerie Pharmaceuticals, Inc. had Shareholders' Equity of -$163.98 million as of 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-11-04
- 2022-09-30: Stockholders' Equity Attributable to Parent -$163.98M.
- 2022-06-30: Stockholders' Equity Attributable to Parent -$141.13M.
- 2022-03-31: Stockholders' Equity Attributable to Parent -$125.71M.
- 2021-12-31: Stockholders' Equity Attributable to Parent -$17.33M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2022-09-30 | -$163.98M 10-Q · filed 2022-11-04 |
| 2022-06-30 | -$141.13M 10-Q · filed 2022-11-04 |
| 2022-03-31 | -$125.71M 10-Q · filed 2022-11-04 |
| 2021-12-31 | -$17.33M 10-Q · filed 2022-11-04 |
| 2021-09-30 | -$72.88M 10-Q · filed 2022-11-04 |
| 2021-06-30 | -$39.61M 10-Q · filed 2022-11-04 |
| 2021-03-31 | -$10.37M 10-Q · filed 2022-11-04 |
| 2020-12-31 | $23.97M 10-Q · filed 2022-11-04 |
| 2020-09-30 | $60.10M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $89.81M 10-Q · filed 2021-11-05 |
| 2020-03-31 | $127.21M 10-Q · filed 2021-11-05 |
| 2019-12-31 | $166.95M 10-K · filed 2022-02-25 |
| 2019-09-30 | $209.20M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $155.76M 10-Q · filed 2020-11-06 |
| 2019-03-31 | $192.15M 10-Q · filed 2020-11-06 |
| 2018-12-31 | $227.81M 10-K · filed 2022-02-25 |
| 2018-09-30 | $268.58M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $194.88M 10-Q · filed 2019-11-07 |
| 2018-03-31 | $236.27M 10-Q · filed 2019-11-07 |
| 2017-12-31 | $135.60M 10-K · filed 2021-02-26 |
| 2017-09-30 | $159.27M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $185.04M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $84.12M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $105.34M 10-K · filed 2020-02-24 |
| 2016-09-30 | $128.36M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$17.40M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$155.00K 10-Q · filed 2016-05-03 |
| 2015-12-31 | $18.77M 10-K · filed 2019-03-01 |
| 2015-09-30 | $32.48M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $33.86M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $48.62M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $28.04M 10-K · filed 2018-03-01 |
| 2014-09-30 | $42.16M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $52.86M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $62.27M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $66.98M 10-K · filed 2017-03-09 |
| 2013-09-30 | -$83.67M 10-Q · filed 2013-12-05 |
| 2012-12-31 | -$63.92M 10-K · filed 2016-03-02 |
| 2011-12-31 | -$48.70M 10-K · filed 2015-02-27 |
| 2010-12-31 | -$35.57M 10-K · filed 2014-03-26 |
| 2009-12-31 | -$27.21M 10-K · filed 2014-03-26 |
| 2008-12-31 | -$19.30M 10-K · filed 2014-03-26 |
| 2007-12-31 | -$11.52M 10-K · filed 2014-03-26 |
| 2006-12-31 | -$4.84M 10-K · filed 2014-03-26 |
| 2005-12-31 | -$764.00K 10-K · filed 2014-03-26 |